Linkedin
Research Interests:
• Closed, automated technologies for cell and gene therapy manufacturing
• cGMP manufacturing of cell therapies for phase 1 clinical trials
• CRISPR-based approaches to cell therapy manufacturing
• Point of care and distributed manufacturing models for autologous cell therapies
• Analytic assay development for cell and gene therapies
• Viral vector development and manufacturing
Team leader for cellular therapy product development, manufacturing, and clinical trials. Experience building GxP systems including QA, QC, and regulatory programs. US-trained and board-certified pathologist and immunologist with 360-degree view of science, medicine, and business aspects of cellular therapy development. I have led cellular therapy development and manufacturing projects with academic, major pharma, and smaller biotech partners. Experience with investigational new drug (IND) applications and other interactions with U.S. FDA.
Clinical service as Medical Director of the Clinical Laboratories, with a focus on lab test utilization and clinician education.
Education:
2014-2015, Fellowship in Transfusion Medicine and Blood Banking at University of California San Francisco
2012-2016, Residency in Laboratory Medicine at University of California San Francisco
2004-2012, MD at University of California, San Francisco
2004-2010, PhD in Immunology at University of California, San Francisco (Lab of Dr. Jeffrey Bluestone)
2000-2004, A.B. in Biochemical sciences, Harvard University
Affiliations:
2017-2022, University of California San Francisco, Dept. of Laboratory Medicine, Assistant Adjunct Professor
Publications:
Here is a link to the publications of Dr. Jonathan Esensten in Pubmed: a database of scientific articles in the fields of medicine and life sciences
